Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

BACKGROUND: Recent experimental studies have revealed that n-3 fatty acids, such as eicosapentaenoic acid (EPA) regulate postprandial insulin secretion, and correct postprandial glucose and lipid abnormalities. However, the effects of 6-month EPA treatment on postprandial hyperglycemia and hyperlipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawada, Takahiro, Tsubata, Hideo, Hashimoto, Naoko, Takabe, Michinori, Miyata, Taishi, Aoki, Kosuke, Yamashita, Soichiro, Oishi, Shogo, Osue, Tsuyoshi, Yokoi, Kiminobu, Tsukishiro, Yasue, Onishi, Tetsuari, Shimane, Akira, Taniguchi, Yasuyo, Yasaka, Yoshinori, Ohara, Takeshi, Kawai, Hiroya, Yokoyama, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002116/
https://www.ncbi.nlm.nih.gov/pubmed/27565734
http://dx.doi.org/10.1186/s12933-016-0437-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002116/
https://www.ncbi.nlm.nih.gov/pubmed/27565734
http://dx.doi.org/10.1186/s12933-016-0437-y

Ejemplares similares